- Filed
- Mar 10, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 6, 2026 | 34.3M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 34.66M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 34.6M sh |
| Shares Diluted restated | Q3 2026 · Jan 25, 2025 | 30.64M sh |
| Shares Diluted restated | Q3 2026 · Jan 25, 2025 | 23.52M sh |
| Stock Repurchased | Q3 2026 · Jan 31, 2026 | $0 |
| Stock Repurchased | Q3 2026 · Jan 25, 2025 | $4K |
| Capex | Q3 2026 · Jan 31, 2026 | $11.78M |
| Capex restated | Q3 2026 · Jan 25, 2025 | $9.79M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | −$30.75M |
| Operating Cash Flow restated | Q3 2026 · Jan 25, 2025 | −$138.04M |
| Long Term Debt | Q3 2026 · Jan 31, 2026 | $138.4M |
| Long Term Debt | Q3 2026 · May 3, 2025 | $103.1M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $10.14M |
| Cash And Equivalents | Q3 2026 · May 3, 2025 | $9.06M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $289.97M |
| Stockholders Equity | Q3 2026 · Nov 1, 2025 | $283.24M |
| Stockholders Equity | Q3 2026 · Aug 2, 2025 | $256.45M |
| Stockholders Equity | Q3 2026 · May 3, 2025 | $272.19M |
| Stockholders Equity restated | Q3 2026 · Jan 25, 2025 | $292.95M |
| Stockholders Equity restated | Q3 2026 · Oct 26, 2024 | $211.44M |
| Stockholders Equity restated | Q3 2026 · Jul 27, 2024 | $149.78M |
| Stockholders Equity restated | Q3 2026 · Apr 27, 2024 | $80.4M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $579.81M |
| Current Liabilities | Q3 2026 · May 3, 2025 | $279.23M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $840.33M |
| Total Liabilities | Q3 2026 · May 3, 2025 | $518.1M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $825.75M |
| Current Assets | Q3 2026 · May 3, 2025 | $465.39M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $1.13B |
| Total Assets | Q3 2026 · May 3, 2025 | $790.29M |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $0.19 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $0.39 |
| Eps Diluted restated | Q3 2026 · Jan 25, 2025 | $0.59 |
| Eps Diluted restated | Q3 2026 · Jan 25, 2025 | −$1.82 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $0.19 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $0.39 |
| Eps Basic restated | Q3 2026 · Jan 25, 2025 | $0.59 |
| Eps Basic restated | Q3 2026 · Jan 25, 2025 | −$1.82 |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $72.55M |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $217.71M |
| Sga Expense | Q3 2026 · Jan 25, 2025 | $71.56M |
| Sga Expense | Q3 2026 · Jan 25, 2025 | $211.52M |
| Net Income | Q3 2026 · Jan 31, 2026 | $6.66M |
| Net Income | Q3 2026 · Jan 31, 2026 | $13.39M |
| Net Income | Q3 2026 · Nov 1, 2025 | $25M |
| Net Income | Q3 2026 · Aug 2, 2025 | −$18.27M |
| Net Income restated | Q3 2026 · Jan 25, 2025 | $17.94M |
| Net Income restated | Q3 2026 · Jan 25, 2025 | −$42.82M |
| Net Income restated | Q3 2026 · Oct 26, 2024 | $43.16M |
| Net Income restated | Q3 2026 · Jul 27, 2024 | −$103.93M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $14.62M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $32.25M |
| Operating Income restated | Q3 2026 · Jan 25, 2025 | $18.92M |
| Operating Income restated | Q3 2026 · Jan 25, 2025 | $27.35M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $96.1M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $281.31M |
| Gross Profit restated | Q3 2026 · Jan 25, 2025 | $93.75M |
| Gross Profit restated | Q3 2026 · Jan 25, 2025 | $267.22M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $418.99M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $1.17B |
| Cost Of Revenue restated | Q3 2026 · Jan 25, 2025 | $369.08M |
| Cost Of Revenue restated | Q3 2026 · Jan 25, 2025 | $1.06B |
| Revenue | Q3 2026 · Jan 31, 2026 | $471.83M |
| Revenue | Q3 2026 · Jan 31, 2026 | $1.34B |
| Revenue | Q3 2026 · Jan 25, 2025 | $419.66M |
| Revenue | Q3 2026 · Jan 25, 2025 | $1.23B |